Pharma

Your Article Summary

See Latest Articles

AstraZeneca and Merck and Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
Merck & Co., 06/02/09

AstraZeneca and Merck and Co., Inc. announced a collaboration to research a novel combination anticancer regimen composed of two investigational compounds, MK-2206 from Merck and AZD6244 from AstraZeneca.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
Takeda Pharmaceuticals North America, 12/08/09

Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN (pralatrexate injection)
Allos Therapeutics, 12/07/09

 See all of M&A/Partnerships